30/01/2026
SAFETY ALERT - QUETIAPINE ORAL SUSPENSION
https://www.gov.uk/drug-device-alerts/national-patient-safety-alert-class-1-medicines-recall-notification-recall-of-quetiapine-oral-suspension-unlicensed-medicine-manufactured-by-eaststone-limited-due-to-a-potential-for-overdosing-natpsa-slash-2026-slash-002-slash-mhr -documents
A manufacturing error has been identified for quetiapine oral suspension (liquid) made by Eaststone Limited, which means the product contains twice as much quetiapine compared to the amount that was prescribed.
Your pharmacist should contact you if you have been dispensed the impacted products and ask you to confirm if you still have some medicine within your possession. However, it is important that if you are taking quetiapine oral suspension, you should check to see if you have any of the specific batches at home (see attached link for affected batch numbers). The batch number and expiry date can be found on the bottle and/or dispensing label. If you are unsure or unable to locate the batch number and expiry date, please contact your pharmacist for further advice.
Patients should be aware of the symptoms of overdose such as extreme drowsiness, vomiting, dizziness or confusion, slow or shallow breathing. If they experience any of these symptoms, then they should seek immediate medical assistance or visit the nearest accident and emergency department.
Patients are advised to not stop taking their medication until they have spoken to their doctor. This is because suddenly stopping your medication also carries risks of severe side effects. Your pharmacist will contact you as soon as possible to consider review of your treatment and to discuss any potential side effects experienced and ongoing monitoring. They will also advise on switching to an alternative treatment. Patients who have taken the affected batches previously may also be contacted for a review.
Any patient that may be worried they have taken an affected batch can contact their healthcare professional to discuss any questions they may have. Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card Scheme https://yellowcard.mhra.gov.uk/
Eaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for the safety of patients.
